30 and 60 Day Clinical Trial Results:

Fasting Glucose

Benefits Beyond Blood Sugar

30 Day Triglyceride Reduction

60 Day LDL Reduction

30 Day Clinical Trial Results:

Percent change of fasting serum blood glucose and triglycerides after 30 days.

Randomized double-blind placebo controlled trial with 60 non-smoking type 2 diabetes men and women. Treatment group received the same dosage of active ingredient in Diabatrol® twice daily for 30 days. All patients were taking prescription anti-diabetic drugs before and during the trill, any changes were contributed to the only variable, the active ingredient in Diabatrol®. No patient was taking a lipid lowering medication or had uncontrolled hypertension. Results are group averages comparing baseline with final results. Analysis of food records showed that dietary intake did not change over the study duration, the mean energy, fat, protein and carbohydrate intakes were not significantly different among groups. Results from the treatment group were statistically significant when compared to the placebo group. (P<0.001 to P<0.013)

60 Day Clinical Trial Results:

Percent change of fasting serum blood glucose, A1c, and LDL cholesterol (bad cholesterol) after 60 days.

Randomized cross-over trial. 57 type 2 diabetic men and women. Treatment group received the same dosage of active ingredient in Diabatrol® twice daily for 60 days. All patients were taking prescription anti-diabetic drugs before and during the trial. The mean energy, fat, protein and carbohydrate intakes were not significantly different among groups.

A1c Improvement in 60-day trial:

Day 0, A1c value: 10.7
Day 60, A1c value: 9.1

Average results:  1.6 point reduction

*All these results are statistically significant.